Literature DB >> 27443698

Epidemiology of Ureaplasma urealyticum and Mycoplasma hominis in the semen of male outpatients with reproductive disorders.

Xiaofei Zhu1, Min Li1, Huiling Cao1, Xuewen Yang1, Chunbing Zhang1.   

Abstract

The aim of the present study was to investigate the association between Mycoplasma infection and infertility in male outpatients among a Chinese population. Epidemiological data, including prevalence, age distribution and antibiotic resistance profile of patients with an Ureaplasma urealyticum or Mycoplasma hominis infection were collected between 2009 and 2012. Among the 7,374 individuals analyzed, 3,225 patients (43.7%) were determined to be positive for infection with U. urealyticum, M. hominis or for both Mycoplasmas. Among the positive cultures, U. urealyticum was detected most frequently, while M. hominis was rarely found. The age range of 25-34 years was the preferred period for the positive detection. Tetracyclines and josamycin were the most effective agents against both genital Mycoplasmas, including in the case of co-infection. Macrolides (erythromycin, roxithromycin, azithromycin, clarithromycin except for josamycin) were effective against the majority of U. urealyticum clinical isolates, but were naturally resisted by M. hominis in this study. Fluoroquinolones had the lowest activity against U. urealyticum, particularly in cases of M. hominis co-infection. Furthermore, fluoroquinolones showed a similar pattern of drug resistance against M. hominis to that of U. urealyticum. Antibiotic resistance did not vary significantly over the test period. Notably, an elevated multi-drug resistance rate was observed in patients co-infected with both Mycoplasmas. In light of the epidemiological characteristics of genital Mycoplasmas in male infertility patients, the present results may aid Chinese clinicians to implement rational drug usage and avoid the overuse of antibiotics.

Entities:  

Keywords:  Mycoplasma hominis; Ureaplasma urealyticum; antimicrobial susceptibility; infertility; semen

Year:  2016        PMID: 27443698      PMCID: PMC4950889          DOI: 10.3892/etm.2016.3409

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  24 in total

1.  Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis.

Authors:  P M Furneri; G Rappazzo; M P Musumarra; P Di Pietro; L S Catania; L S Roccasalva
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 2.  Mycoplasmas and their host: emerging and re-emerging minimal pathogens.

Authors:  Christine Citti; Alain Blanchard
Journal:  Trends Microbiol       Date:  2013-02-16       Impact factor: 17.079

Review 3.  Male infertility: a public health issue caused by sexually transmitted pathogens.

Authors:  Fabrícia Gimenes; Raquel P Souza; Jaqueline C Bento; Jorge J V Teixeira; Silvya S Maria-Engler; Marcelo G Bonini; Marcia E L Consolaro
Journal:  Nat Rev Urol       Date:  2014-10-21       Impact factor: 14.432

4.  Molecular detection of potential sexually transmitted pathogens in semen and urine specimens of infertile and fertile males.

Authors:  Eman A Abusarah; Ziad M Awwad; Ekatherina Charvalos; Asem A Shehabi
Journal:  Diagn Microbiol Infect Dis       Date:  2013-09-29       Impact factor: 2.803

Review 5.  Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!

Authors:  Patrick Horner; Karla Blee; Elisabeth Adams
Journal:  Curr Opin Infect Dis       Date:  2014-02       Impact factor: 4.915

6.  Gene-gene and gene-environment interactions on risk of male infertility: Focus on the metabolites.

Authors:  Weiyue Hu; Minjian Chen; Wei Wu; Jing Lu; Dan Zhao; Feng Pan; Chuncheng Lu; Yankai Xia; Lingqing Hu; Daozhen Chen; Jiahao Sha; Xinru Wang
Journal:  Environ Int       Date:  2016-03-09       Impact factor: 9.621

7.  Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction.

Authors:  B de Barbeyrac; C Bernet-Poggi; F Fébrer; H Renaudin; M Dupon; C Bébéar
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

Review 8.  Susceptibility of mycoplasmas to antimicrobial agents: clinical implications.

Authors:  W M McCormack
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

9.  Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.

Authors:  Qing-Yong Wang; Rong-Hai Li; Lu-Qing Zheng; Xiao-Hong Shang
Journal:  J Microbiol Immunol Infect       Date:  2014-07-28       Impact factor: 4.399

10.  Presence of aerobic micro-organisms and their influence on basic semen parameters in infertile men.

Authors:  E Filipiak; K Marchlewska; E Oszukowska; R Walczak-Jedrzejowska; A Swierczynska-Cieplucha; K Kula; J Slowikowska-Hilczer
Journal:  Andrologia       Date:  2014-09-11       Impact factor: 2.775

View more
  6 in total

1.  Prevalence and antimicrobial resistance of Ureaplasma spp. and Mycoplasma hominis isolated from semen samples of infertile men in Shanghai, China from 2011 to 2016.

Authors:  Y-H Zhou; H-X Ma; Y Yang; W-M Gu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-08       Impact factor: 3.267

2.  Detection and Evaluation of Macrolide Resistance (Erythromycin) in Mycoplasma hominis Isolated from Endocervical Specimens of Patients Referring to Ibn Sina Infertility Treatment Centre, Tehran, Iran.

Authors:  Faezeh Nazarzadeh; Mohammad Hossein Ahmadi; Soheila Ansaripour; Mohammad Niakan; Iman Pouladi
Journal:  Int J Fertil Steril       Date:  2022-05-08

3.  Epidemiology of genital infections caused by Mycoplasma hominis, M. genitalium and Ureaplasma urealyticum in Iran; a systematic review and meta-analysis study (2000-2019).

Authors:  Khadijeh Moridi; Mohammad Hemmaty; Amir Azimian; Mohammad Hosein Fallah; Hamid Khaneghahi Abyaneh; Kiarash Ghazvini
Journal:  BMC Public Health       Date:  2020-06-29       Impact factor: 3.295

4.  Spread of multidrug resistance among Ureaplasma serovars, Tunisia.

Authors:  Safa Boujemaa; Béhija Mlik; Amina Ben Allaya; Helmi Mardassi; Boutheina Ben Abdelmoumen Mardassi
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-23       Impact factor: 4.887

5.  Detection of Ureaplasma urealyticum by Catalytic Hairpin Assembly Combined with a Lateral Flow Immunoassay Strip.

Authors:  Feng Xiao; Qingrong Qu; Mingyuan Zou; Feiya Su; Huina Wu; Yan Sun; Meiling Zhou; Fengfeng Zhao; Yuming Yao; Gulinaizhaer Abudushalamu; Yaya Chen; Chen Zhang; Xiaobo Fan; Guoqiu Wu
Journal:  ACS Omega       Date:  2022-09-15

6.  Analysis of the Clinical Features of Intrauterine Ureaplasma urealyticum Infection in Preterm Infants: A Case-Control Study.

Authors:  Tong Sun; Jianhua Fu
Journal:  Front Pediatr       Date:  2021-12-09       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.